Autopsy report · NCT02953769

Prevena Incision Management System Wound Care

“Principal Investigator left the Hospital and did not transfer the study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 1 year 7 months before it stopped.
• 61 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

AdventHealth

Sponsor type

University, hospital or other

Conditions

Ventral Hernia

Participants

61

Sites

1

Countries

United States

Trials that died the same way

• Heat-not-burn Tobacco Product to Aid in Switching From Combustible to Noncombustible Nicotine (IQOS)
  “Investigator left institution and did not retain the study” (82% match in meaning)
• Continuous Femoral and Tibial Nerve Blocks in TKA Patients
  “Principal Investigator left institution--no subjects completed the study” (79% match in meaning)
• Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer
  “Principal investigator left the institution” (78% match in meaning)
• Residual Extensor Lag Approximately 1 Month After Splint or Cast Immobilization of a Mallet Finger
  “Due to the investigator leaving the institution, the study was terminated” (77% match in meaning)
• Digital Therapeutic Lifestyle Intervention Program for Patients With MASLD
  “Principal investigator left the institution and study was never funded” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.